November 2, 2024
Florida's surgeon general issued a call Wednesday for healthcare providers to stop utilizing Pfizer and Moderna COVID-19 mRNA vaccines due to concerns about genetic contamination.

Floridas surgeon general issued a call Wednesday for healthcare providers to stop utilizing Pfizer and Moderna COVID-19 mRNA vaccines due to concerns about genetic contamination.

“Providers concerned about patient health risks associated with COVID-19 should prioritize patient access to non-mRNA COVID-19 vaccines and treatment,” said Surgeon General Joseph Ladapo in a press statement. “It is my hope that, in regard to COVID-19, the FDA will one day seriously consider its regulatory responsibility to protect human health, including the integrity of the human genome.”

HOUSE REPUBLICANS MOVING SWIFTLY TO START MAYORKAS IMPEACHMENT ON JAN. 10

In December, Lapado sent a letter to the Food and Drug Administration and the Centers for Disease Control and Prevention inquiring about recent reports of foreign DNA material in Pfizer and Moderna mRNA vaccines. Ladapo said if the vaccine is “an efficient vehicle for delivery of the mRNA,” then it may be “an equally efficient vehicle for delivering contaminant DNA into human cells,” a process known as DNA integration.

The FDA responded to the letter shortly thereafter but, Ladapo said, did not provide evidence to the contrary refuting the potential for DNA integration.

“The FDA’s response does not provide data or evidence that the DNA integration assessments they recommended themselves have been performed. Instead, they pointed to genotoxicity studies – which are inadequate assessments for DNA integration risk,” Ladapo said. “If the risks of DNA integration have not been assessed for mRNA COVID-19 vaccines, these vaccines are not appropriate for use in human beings.”

CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER

The surgeon general’s statement does not prohibit the use of mRNA COVID-19 vaccines in the Sunshine State, but it does encourage physicians and healthcare providers to seek non-mRNA vaccines, such as Novavax.

The FDA has not responded to the Washington Examiner’s request for comment.

This is a developing story.

Leave a Reply